Victoza 18mg for subcutaneous injection

Victoza 18mg for subcutaneous injection (YJ code: 2499410G1021, standard: 18 mg 3mL x 1 kit), manufactured by Novo Nordisk Pharma, contains liraglutide and is used along with diet and exercise to improve blood sugar in adults and children 10 years and older with type 2 diabetes mellitus. It also helps reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease.